Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
UPDATE: Chardan Capital Markets Upgrades Forte Biosciences Inc. (FBRX) to Neutral
-
Forte Biosciences Inc. (FBRX) PT Lowered to $105 at Chardan Capital Markets
-
Forte Biosciences, Inc. to Present at the Chardan Annual Microbiome Medicines Summit on March 8th
-
Forte Biosciences Announces Closing of $46.0 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Forte Biosciences (FBRX) Announces Pricing of $40 Million Public Offering of Common Stock at $28.50/sh
-
Forte Biosciences Announces Pricing of $40.0 Million Public Offering of Common Stock
-
Forte Biosciences (FBRX) Announces Proposed Public Offering of Common Stock
-
Forte Biosciences Announces Proposed Public Offering of Common Stock
